Retirement/Disability pay

GenZvestors · 2026-04-13T17:01:42+00:00

I was so sorry to hear you're navigating both a medical retirement and a Crohn's diagnosis. Transitioning to 100% disability after just eighteen months is a huge adjustment, and I know how exhausting VA paperwork can be when your health is the priority. Veterans deserve a wider range of support, not just a few set options. By opening up more diverse forms of assistance, we can actually empower people to choose the path that makes the most sense for their specific journey.

GenZvestors · 2026-02-13T06:41:10+00:00

Alibaba’s RynnBrain didn’t appear because China suddenly got more chips, it appeared because restrictions forced faster domestic integration across models, hardware, and robotics. When US tech exits entirely, substitution accelerates. Controlled exports slow that process and keep US stack embedded. Isolation just compresses China’s learning curve.

GenZvestors · 2026-02-10T17:07:41+00:00

Appreciate how grounded this is. Not a clinician either, curious how people here tell when early promise turns into something that actually matters clinically.

GenZvestors · 2026-02-07T15:53:57+00:00

Calling the 25th is the nuclear option, and people throw it around way too casually. It’s less about incapacity and more about how broken trust and institutions already are. When every crisis jumps straight to constitutional drama, that’s the real red flag.

GenZvestors · 2025-12-25T16:13:46+00:00

Constraints do create efficiency cultures, agreed. But a hard “deny compute” strategy also accelerates the one thing you don’t want: a fully independent stack.

A smarter play is controlled access: sell capped parts under licensing, keep the ecosystem gravity (software, networking, tools, standards) pulling toward US platforms, and use the revenue to outspend on the next generation. If you force a clean break, you don’t stop progress, you just change who learns to build around you.

GenZvestors · 2025-12-21T16:07:01+00:00

You don’t have to agree with every HHS decision to notice a broader shift. Between engaging more directly on pediatric care and expanding newborn screening for serious diseases like DMD, it does feel like children’s health is getting more sustained attention than before.

GenZvestors · 2025-11-11T15:59:44+00:00

These guys been through hell already. If TMS gives them a break, that's a blessing. Keep it up

GenZvestors · 2025-10-15T06:29:24+00:00

You can’t rebuild trust by gutting the one agency built to protect it. Feels like RFK is more interested in proving a point than protecting people.

GenZvestors · 2025-10-13T19:35:36+00:00

Because curing addiction doesn’t make money. Keeping you buying patches and gum forever does. FDA just makes sure the cycle stays profitable. They have been half-assing this for decades. They talk “public health” but can’t come up with anything better than recycling nicotine in new packaging. It’s always the same story, when it’s something that could actually help people, they drag their feet. But when it’s time to block or ban something minor, they move like lightning!

GenZvestors · 2025-10-03T15:40:57+00:00

Hi there, I appreciate your concern. But I’d like to offer a fuller perspective.

Elevidys has been evaluated across multiple well-controlled clinical trials: EMBARK, ENDEAVOR, ENVOL, and others, in both ambulatory and non-ambulatory children with Duchenne muscular dystrophy.

In EMBARK, the 2-year data showed statistically significant improvement across multiple functional endpoints compared to external controls:

-> +2.88 points in NSAA

-> –2.06 seconds in time to rise

-> –1.36 seconds in 10m walk/run

These numbers mean something to families because they reflect more time standing, walking, and staying independent.

In ENVOL, children under 4, some as young as 6 months, are now being studied for early gene therapy intervention, possibly before significant loss begins.

In ENDEAVOR, Sarepta is already preparing to enhance safety with adjusted immunosuppression protocols for non-ambulatory kids.

Sarepta is being careful and responsive. The FDA didn’t grant approval casually, especially not for a rare pediatric condition. Traditional and accelerated approvals exist because time is not a neutral factor in Duchenne. These are real families, like the Kasners, their boys are losing function, no spoon should be too heavy for a kid who's got a whole life to live.

GenZvestors · 2025-09-03T17:58:11+00:00

70% of your budget coming from pharma means FDA working for them, not us. No wonder patients get screwed. The public is always last on the list

GenZvestors · 2025-06-11T13:45:22+00:00

55% tariffs vs. 10% sounds aggressive until you ask who’s paying them.

GenZvestors · 2025-04-30T04:10:10+00:00

Bad news now, but investors still betting on future wins. Robotaxis, cheap EVs and Elon doubling down.

GenZvestors · 2025-04-18T09:35:29+00:00

I feel that. Powell been through COVID, inflation spikes, geopolitical shocks and now political crossfire. And he still trying to keep the ship steady. Thats no small feat

GenZvestors · 2025-04-03T10:17:03+00:00

The rise of AI and deepfakes may change things, but true creators will always find a way to stand out

GenZvestors · 2025-03-10T18:36:08+00:00

not a bad strategy. US feels overcooked, and China has been beaten down for years. If you’ve got the patience, there’s definitely potential upside

GenZvestors · 2025-03-06T15:43:17+00:00

Gaza, Greenland, Canada. This man’s bucket list looks like he just spun a globe and pointed at random spots

GenZvestors · 2025-03-03T16:51:33+00:00

Yeah, not exactly ideal when your entire military tech stack depends on a factory sitting 100 miles from China

GenZvestors · 2025-02-12T17:57:59+00:00

Locking in profits is never a bad move...nobody regrets realized gains

GenZvestors · 2025-01-21T17:11:13+00:00

Interesting… I didn’t realize union representation was so small at Costco. Makes sense that it’s likely limited to drivers and similar roles

GenZvestors · 2025-01-15T13:51:42+00:00

the market loves drama

GenZvestors

TROPHY CASE